Literature DB >> 11770359

Is erectile dysfunction a marker for cardiovascular disease?

M Kirby1, G Jackson, J Betteridge, K Friedli.   

Abstract

There is now significant evidence that erectile dysfunction (ED) can be a symptom of cardiovascular disease, and can act as a marker for disease progression. National Health Service (NHS) prescribing restrictions on treatments for ED have recently been reviewed by the Department of Health, and current arrangements will not change. Unrestricted availability of licensed treatments for ED on the NHS, irrespective of the cause of the ED, may encourage men to present for investigation, enabling early detection of cardiovascular disease. Sildenafil citrate (Viagra), an effective treatment for ED, can also have a direct beneficial effect on cardiovascular disease. Unrestricted NHS availability of ED treatments such as sildenafil could facilitate greater achievement of National Service Framework targets for coronary heart disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11770359

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  18 in total

1.  Association between coronary artery disease severity and overactive bladder in geriatric patients.

Authors:  Muhammet Fatih Kilinc; Erdogan Yasar; Halil Ibrahim Aydin; Yildiray Yildiz; Omer Gokhan Doluoglu
Journal:  World J Urol       Date:  2017-10-14       Impact factor: 4.226

2.  Energy restriction ameliorates metabolic syndrome-induced cavernous tissue structural modifications in aged rats.

Authors:  Inês Tomada; Dalila Fernandes; João Tiago Guimarães; Henrique Almeida; Delminda Neves
Journal:  Age (Dordr)       Date:  2012-09-26

3.  Telmisartan, ramipril and their combination improve endothelial function in different tissues in a murine model of cholesterol-induced atherosclerosis.

Authors:  N Schlimmer; M Kratz; M Böhm; M Baumhäkel
Journal:  Br J Pharmacol       Date:  2011-06       Impact factor: 8.739

Review 4.  Treatment of erectile dysfunction in patients with cardiovascular disease : guide to drug selection.

Authors:  Graham Jackson
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 5.  [Erectile dysfunction. Epidemiology, physiology, etiology, diagnosis and therapy].

Authors:  H Derouet; J Osterhage; H Sittinger
Journal:  Urologe A       Date:  2004-02       Impact factor: 0.639

6.  Modifiable risk factors for erectile dysfunction: an assessment of the awareness of such factors in patients suffering from ischaemic heart disease.

Authors:  D Kałka; Z Domagała; A Rakowska; K Womperski; R Franke; E Sylwina-Krauz; J Stanisz; M Piłot; J Gebala; L Rusiecki; W Pilecki
Journal:  Int J Impot Res       Date:  2015-12-03       Impact factor: 2.896

7.  The relationship between erectile dysfunction and paroxysmal lone atrial fibrillation.

Authors:  Samet Yılmaz; Mevlüt Serdar Kuyumcu; Mehmet Kadri Akboga; Fatih Sen; Kevser Gülcihan Balcı; Mustafa Mücahit Balcı; Özcan Özeke; Dursun Aras; Sinan Aydoğdu
Journal:  J Interv Card Electrophysiol       Date:  2016-02-16       Impact factor: 1.900

Review 8.  Sexual dysfunction in essential hypertension: myth or reality?

Authors:  Michael Doumas; Stella Douma
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-04       Impact factor: 3.738

9.  The validity of a single-question self-report of erectile dysfunction. Results from the Massachusetts Male Aging Study.

Authors:  Amy B O'Donnell; Andre B Araujo; Irwin Goldstein; John B McKinlay
Journal:  J Gen Intern Med       Date:  2005-06       Impact factor: 5.128

10.  Male erectile dysfunction and microalbuminuria in adult nigerians with essential hypertension.

Authors:  Olusegun Adesola Busari; Oladimeji George Opadijo; Timothy Olusegun Olarewaju; Yusuf Olatunji Oladosu
Journal:  N Am J Med Sci       Date:  2013-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.